FGF23 and cardiovascular disorder: As an example, the steep and early increase of the bone-derived phosphaturic FGF-23 keeps serum phosphate well within the normal range and at the same time triggers left ventricular hypertrophy and cardiovascular disease in CKD patients [54–56].